Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CBD and driving in France: 3 years and €9,000 since 2025

By

8 min readUpdated on

Driving after taking CBD is not in itself an offence, since CBD is not a narcotic and roadside tests do not look for it. The risk lies in the THC of full-spectrum products. Once THC is detected in saliva or blood, the offence under article L235-1 of the French Highway Code is made out whatever the dose. Since 11 July 2025, it carries up to 3 years in prison and a €9,000 fine.

Steering wheel and lit gauges of a car at night, seen from the driver's seat

Key takeaways

  • Under the law of 9 July 2025, the penalty went from 2 years and €4,500 to 3 years and €9,000, and from 3 years and €9,000 to 5 years and €15,000 when alcohol is also involved.
  • On 21 June 2023, France's Court of Cassation held that whether the product is legal has "no bearing", "whatever the dose absorbed".
  • According to a meta-analysis of 28 publications, THC levels in blood or saliva say little about how impaired a driver is.
  • THC can be detected in saliva for 6 to 8 hours after occasional use, and for up to 24 hours with regular use.
  • The risk disappears only with a product whose analysis reports THC as not detected.

What the law of 9 July 2025 changed

Law no. 2025-622 of 9 July 2025 appeared in the Official Journal the following day. It created the offence of road homicide, toughened driving offences and applies to acts committed from 11 July 2025. For drug driving, it raises the maximum penalties set by article L235-1 of the Highway Code.

OffenceBefore 11 July 2025Since 11 July 2025
Driving after using narcotics2 years, €4,5003 years, €9,000
Same offence, with an illegal alcohol level3 years, €9,0005 years, €15,000

Under the new article 221-18 of the Penal Code, a fatal crash caused by a driver whose test shows narcotic use is now called road homicide. It carries 7 years in prison and a €100,000 fine, rising to 10 years and €150,000 when several aggravating circumstances combine.

For driving after using narcotics, the official « Drogue au volant » page on service-public.fr lists further consequences: the loss of 6 licence points, a licence suspension of up to 5 years with no exemption for work, and an awareness course at your own expense. Refusing the roadside test stops nothing: a saliva or blood sample is then taken. Refusing those checks is a separate offence, punished by the same 3 years and €9,000 and the loss of 6 points (article L235-3), with a licence suspension of up to 3 years.

A year later, the law of 18 August 2026 added a separate offence in article L237-1: driving after having "manifestly consumed" psychoactive substances listed by decree. Aimed at deliberate, diverted or excessive use, it leaves the THC rule untouched, and that rule is still article L235-1.

Why legal CBD can be enough to break the law

Hemp products may contain up to 0.30% Δ⁹-THC. This limit applies to sale and says nothing about driving, as our article on the legal THC level explains. A flower at 0.2% THC holds 2 mg of THC per gram, and regular smoking or vaping can leave enough THC to trigger a test.

MILDECA, which coordinates French drug policy, confirms this on its page about CBD: traces of THC in CBD products "can pass into the blood or saliva of their consumers".

Judges draw no distinction either. The Court of Cassation held, in a ruling of 21 June 2023 (appeal no. 22-85.530), that the permission to sell hemp derivatives under 0.30% THC has "no bearing" on the offence. Once use is established, the offence is made out "whatever the dose absorbed", so a driver cannot rely on having bought a legal product.

THC levels do not measure impairment

French law punishes the presence of THC, whatever the driver's state. This is a choice: for THC, science has no equivalent of the 0.5 g of alcohol per litre of blood used for drink-driving.

An Australian team combined 28 publications covering 822 measures of driving-related performance. Their meta-analysis published in 2022 in Neuroscience & Biobehavioral Reviews describes THC concentrations in blood and saliva as "relatively poor indicators" of impairment. Occasional users showed a weak link, and regular users no significant relationship at all.

A 2020 on-road trial in JAMA gives a closer view of the gap. In Maastricht, 26 occasional users vaporised cannabis that was THC-rich, CBD-rich or balanced, or a placebo, and then drove 100 km. THC-rich cannabis made the car weave more in its lane 40 to 100 minutes after use, and the difference was no longer significant 4 to 5 hours later. CBD-rich cannabis gave the same result as placebo. According to the authors, the 13.75 mg dose tested may not reflect typical use.

Timeline from 0 to 24 hours: driving impaired 40 to 100 minutes after vaporised THC, THC detectable in saliva for 6 to 8 hours with occasional use, up to 24 hours with regular use, up to 8 days with heavy use
How long measured impairment lasts versus how long THC is detectable in saliva. Sources: Arkell et al., JAMA, 2020; Drogues Info Service, June 2025

In saliva, THC therefore remains detectable well after the measured effect has worn off. The table of detection times published by Drogues Info Service, France's public drug information service, gives these windows: 6 to 8 hours after occasional use, up to 24 hours with regular use and up to 8 days with heavy daily use. A driver who feels nothing any more can still test positive, which is enough for the offence.

The roadside check, step by step

According to service-public.fr, testing has three stages:

  1. Roadside saliva test. It looks for THC, never CBD.
  2. Confirmation sample. If the test is positive, a second saliva sample goes to a laboratory. That result is the one that counts.
  3. Blood sample, if you ask for one. You must ask for it when the second saliva sample is taken, to reserve a counter-analysis. The counter-analysis itself is then requested within 5 days of being notified of the result.

Our guide CBD and drug testing covers kit thresholds, the molecules tested for and other types of test. Testing at work follows other rules, explained in saliva testing by employers.

Reducing the risk if you use CBD

No official source gives a safe waiting time after using a CBD product. Products differ in how much THC they contain, and the speed at which it clears depends on how often you use them. In practice, this leads to three rules.

  • Do not drive after using a full-spectrum product: full-spectrum flowers, resins and oils contain small but real amounts of THC.
  • If you drive often, choose a product with no detectable THC. An isolate or a THC-free oil removes the risk, provided the batch analysis reports THC as "not detected" and gives its limit of detection.
  • Base your choice on the analysis, which the label cannot replace. Our guide to reading a certificate of analysis shows where to find the Δ⁹-THC line.

For clearance times by type of sample, see how long CBD stays in the body.

Frequently asked questions

CBD on its own raises no legal issue, since it is not a narcotic and no test looks for it. Full-spectrum products, however, contain traces of THC. If these are detected, the offence is made out, legal product or not.

For acts committed from 11 July 2025, driving after using narcotics carries 3 years in prison and a €9,000 fine, or 5 years and €15,000 with alcohol. A fatal crash now counts as road homicide, punishable by 7 years and €100,000.

No. According to service-public.fr, the ban applies "whatever the quantity" consumed. Kit thresholds are technical detection limits and do not mark any tolerated level.

Not reliably. In the 2022 meta-analysis, the link was weak in occasional users and not significant in regular users. The law does not take this into account, since presence alone counts.

Yes. When the second saliva sample is taken, you can ask for a blood sample to reserve a counter-analysis, which you then request within 5 days of being notified of the result. Proving the product was legal, however, has been useless since the ruling of 21 June 2023.


Written by the Phytogrammes team

Each journal article draws on cited primary sources: ANSM, EFSA, EUR-Lex and peer-reviewed publications. Product profiles are distinguished from documented laboratory results. Our approach.

Article published on . CBD is not a medicine.